FinnCap reiterated their corporate rating on shares of LiDCO Group (LON:LID) in a report published on Wednesday, ThisIsMoney.Co.Uk reports.

Shares of LiDCO Group stock opened at GBX 4.60 ($0.06) on Wednesday. The company has a market capitalization of $11.23 million and a price-to-earnings ratio of -5.75. LiDCO Group has a 52 week low of GBX 3.29 ($0.04) and a 52 week high of GBX 8.25 ($0.11).

In related news, insider Phil Cooper purchased 100,000 shares of the company’s stock in a transaction on Tuesday, March 26th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £4,000 ($5,226.71). Insiders acquired 1,000,000 shares of company stock worth $4,900,000 over the last quarter.

About LiDCO Group

LiDCO Group Plc develops, manufactures, and sells hemodynamic monitoring equipment in the United Kingdom, the United States, Continental Europe, and internationally. The company provides a range of closed and open pressure monitoring sets for use in the ICU, operating department, and Cath labs; and Stimpod NMS 450X, a quantitative neuromuscular blocking agent monitor.

Featured Story: FAANG Stocks

Receive News & Ratings for LiDCO Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LiDCO Group and related companies with MarketBeat.com's FREE daily email newsletter.